Prm20 - Clinical Effectiveness and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A Nationwide Population-Based Cohort Study

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2144
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation: Propensity Weighted Nationwide Cohort Study

British Medical Journal
Medicine
2016English

Safety of Once- Or Twice-Daily Dosing of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients With Nonvalvular Atrial Fibrillation: A NOAC-TR Study

Bosnian Journal of Basic Medical Sciences
Medicine
2017English

Use of Non-Vitamin K Antagonist Oral Anticoagulants 2008-2016: A Danish Nationwide Cohort Study

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Effectiveness and Safety of Direct Oral Anticoagulants Compared With Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion

Journal of Clinical Trials in Cardiology
2017English

Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Healthcare Costs of Stroke and Major Bleeding in Patients With Atrial Fibrillation Treated With Non–vitamin K Antagonist Oral Anticoagulants

Journal of Medical Economics
Health Policy
2019English

Discontinuation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Population-Based Cohort Study Using Primary Care Data From the Health Improvement Network in the UK

BMJ Open
Medicine
2019English

Correction: Discontinuation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Population-Based Cohort Study Using Primary Care Data From the Health Improvement Network in the UK

BMJ Open
Medicine
2020English

Risk of Major Bleeding and Stroke Associated With the Use of Vitamin K Antagonists, Nonvitamin K Antagonist Oral Anticoagulants and Aspirin in Patients With Atrial Fibrillation: A Cohort Study

British Journal of Clinical Pharmacology
Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy